Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-01-22
1993-06-22
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530330, 530331, 530800, A61K 3700, C07K 500
Patent
active
052216675
ABSTRACT:
The invention concerns novel renin-inhibitory compounds which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, glaucoma, and diseases caused by retroviruses including HTLV-I -II, and -III. Processes for preparing the compounds, novel intermediates useful in the preparation thereof, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism.
REFERENCES:
patent: 5036054 (1991-07-01), Kaltenbronn
Burger, Medicinal Chemistry, 1960, pp. 565-571, 578-581, 600-601.
Plattner et al. J. Med. Chem. 1988, 31(12):2277-2288.
Bolis et al. J. Med. Chem. 1987, 31(10):1729-1737.
Haber et al. J. Cardiovasc. Pharmacol. 1988, 10 (Suppl. 7):S54-S58.
Kaltenbronn James S.
Repine Joseph T.
Anderson Elizabeth M.
Cashion Jr. Merrell C.
Celsa Bennett
Warner-Lambert & Company
LandOfFree
Renin inhibiting peptides having an .alpha.-heteroatom amino aci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renin inhibiting peptides having an .alpha.-heteroatom amino aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibiting peptides having an .alpha.-heteroatom amino aci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441076